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Abstract
Background: The aim of this study was to evaluate a possible association between malignancy and anxiety disorders (AD) in
Taiwan.
Methods: We employed data from the National Health Insurance system of Taiwan. The AD cohort contained 24,066
patients with each patient randomly frequency matched according to age and sex with 4 individuals from the general
population without AD. Cox’s proportional hazard regression analysis was conducted to estimate the influence of AD on the
risk of cancer.
Results: Among patients with AD, the overall risk of developing cancer was only 1% higher than among subjects without
AD, and the difference was not significant (hazard ratio [HR]=1.01, 95% confidence interval [95% CI]=0.95–1.07). With
regard to individual types of cancer, the risk of developing prostate cancer among male patients with AD was significantly
higher (HR=1.32, 95% CI=1.02–1.71). On the other hand, the risk of cervical cancer among female patients with AD was
marginally significantly lower than among female subjects without AD (HR=0.72, 95% CI=0.51–1.03).
Limitations: One major limitation is the lack of information regarding the life style or behavior of patients in the NHI
database, such as smoking and alcohol consumption.
Conclusions: Despite the failure to identify a relationship between AD and the overall risk of cancer, we found that
Taiwanese patients with AD had a higher risk of developing prostate cancer and a lower risk of developing cervical cancer.
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Introduction
Anxiety disorder (AD) is a chronic disorder, highly prevalent in
the adult population, with the lifetime prevalence in the general
population estimated at 5% in western countries [1,2]. Studies in
Asia have shown an even higher lifetime prevalence [3]. In a study
in Taiwan, Hwu et al. [4] found that the life time prevalence of
AD differed considerably according to geographic sampling area,
ranging from 3.7% to 10.5%. AD often causes sleep disturbance
[5], and has a detrimental effect on health outcomes such as
increased risk of heart disease and respiratory resistance in asthma
[6,7].
In examining the relationship between AD and malignancy,
most studies have focused on the issue of anxiety among patients
with malignancy and found that increased anxiety is not
uncommon among cancer patients [8–10]. However, in this
study, we explored the possibility of reverse causality, to determine
whether AD is a risk or protective factor in the development of
malignancy. Following a review of the literature, we found that
only a limited number of papers discussed or even addressed this
issue, and the association between AD and cancer remains unclear
[11–15]. Recently published meta-analysis focusing only on
prospective studies uncovered the fact that psychological distress,
including depression, anxiety, and poor quality of life, are
associated with a statistically significant (6%) increase in the risk
of cancer [16].
To the best of our knowledge, no nationwide, population-based
studies outlining the possible relationship between AD and cancer
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assess the risk of all forms of cancer among patients with AD in
Taiwan. The results, presented in this paper, were generated from
a retrospective cohort study of patients with AD. The original
database was derived from the National Health Insurance (NHI)
system in Taiwan.
Methods
Database
This study used claims data from the National Health Insurance
Research Database (NHIRD), retrospectively collected from NHI,
representing health care data from .96% of all medical claims in
Taiwan since 1996. The NHI program provides comprehensive
medical services, including ambulatory care, inpatient care,
physical therapy, dental services, prescription drugs, medical
institutions, and registration files with scrambled identifications.
We obtained a representative claims dataset of a sample of one
million enrollees, randomly selected from the entire insured
population included in the NHI program base between 1996 and
2000. The diagnoses in the database were coded using the
International Classification of Diseases 9th Revision of the Clinical
Modification (ICD-9-CM). A more detailed description of the
NHIRD was previously described [17].
Study sample
For the study cohort, we selected patients who had been
diagnosed with AD between 1 January 2000 and 31 December
2002 (ICD-9-CM codes 300.0, 300.2, 300.3, 308.3 and 309.81).
To ensure the accuracy of diagnosis of AD, we selected only
subjects who had been admitted at least three times as a study
cohort. We then excluded patients who had any type of cancer
(ICD-9-CM codes 140–239) prior to the date of indexing. Finally,
we identified a total of 24,066 patients with AD. To assemble a
comparison cohort, we randomly selected 96,104 enrollees without
a history of AD. These controls were matched with the study
cohort at a ratio of 1:4 on frequency of age and sex using the same
exclusion criteria during the same period.
Both study cohorts were followed until a diagnosis of cancer was
made, or until the time the subject was lost to follow-up, death,
termination of insurance, or other causes by the end of 2008.
In addition, we also searched hypertension (ICD-9-CM codes
401–405) and diabetes mellitus (ICD-9-CM codes 150), and
hyperlipidemia (ICD-9-CM codes 272) as comorbidities at the
baseline.
Statistical analysis
A chi-square tests were carried out to examine the differences in
the distribution of socio-demographic factors and comorbidities
between the cohorts with and without AD. Person-years of follow-
up duration were calculated for each person until cancer was
diagnosed or censored. A Poisson regression model was used to
examine the incidence density rates and incidence rate ratio (IRR)
and 95% confidence interval (95% CI) of cancer with categorical
variables were calculated for each cohort. Multivariate Cox
proportional hazard models were used to estimate hazard ratio
(HR) and 95% CI for factors associated with cancer risk. We
performed all analysis using the SAS statistical package (SAS
System for Windows, Version 9.1) with the statistical adopted
significance level at 0.05.
Results
Of the total sample of 120,170 subjects, with a mean age of 54.0
years in the non-AD cohort and 54.1 years in the AD cohort.
When focused on AD group only, we found the AD cohort tended
to comprise more females (64.3%) and was more likely to be
younger (26.9% in 30–44 years of age). Compared to the non-AD
group, the AD cohort tended to live in lower urbanized areas
(28.9% in urbanization level 4 and 5), and to have hypertension
(44.6% vs. 26.7%), diabetes mellitus (11.6% vs. 9.5%) and
hyperlipidemia (24.7% vs. 12.9%) (Table 1).
Table 2 presents a comparison of incidence density of cancer
during the 9-year follow-up period for subjects with and without
AD, according to socio-demographic factors and comorbidities.
The incidence of cancer was slightly higher in the AD cohort than
in the non-AD cohort (7.59 vs. 7.33 per 1,000 person-years), with
an IRR of 1.04 (95% CI=0.98–1.10). The IRR of cancer was
highest in the youngest age group (30–44 years of age, IRR=1.18,
95% CI=0.99–1.40). Among the patients with hypertension, we
observed that patients with AD had a lower incidence than
subjects without AD (10.3 vs. 11.9 per 1,000 person-years;
IRR=0.87, 95% CI=0.80–0.94).
Table 1. Baseline characteristics between anxiety disorder
group and non-anxiety disorder group in 2000–2002.
Variables Anxiety disorder
No N=96,104 Yes N=24,066
n % n % p-value
Sex 0.86
Women 61,768 64.3 15,482 64.3
Men 34,336 35.7 8,584 35.7
Age, years 1.00
30–44 29,292 27.0 7,323 26.9
45–54 24,764 22.8 6,191 22.8
55–64 18,029 16.6 4,524 16.6
$65 24,019 22.1 6,028 22.2
Mean (SD)
{ 54.0 (14.3) 54.1 (13.9) 0.94
Urbanization level ,0.0001
1 28,742 29.9 6,374 26.5
2 27,506 28.6 6,785 28.2
3 16,749 17.4 3,959 16.5
4 12,966 13.5 4,020 16.7
5 10,140 10.6 2,928 12.2
Co-morbidity
Hypertension 25,678 26.7 10,732 44.6 ,0.0001
Diabetes mellitus 9,089 9.5 2,798 11.6 ,0.0001
Hyperlipidemia 12,401 12.9 5,932 24.7 ,0.0001
Urbanization level: 1 indicate the highest level of urbanization and 5 the lowest
Chi-square test,
{student T-test.
Hypertension: ICD-9-CM (A-code): 401–405 (A260 and A269), admission more
than three times.
Diabetes mellitus: ICD-9-CM (A-code): 250 (A181), admission more than twice in
the first year.
Hyperlipidemia: ICD-9-CM (A-code): 272 (A182), admission more than three
times.
doi:10.1371/journal.pone.0036370.t001
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showed that after adjusting for the urbanization level and
comorbidities, patients with AD was not significantly related to
the development of cancer (HR=1.01, 95% CI=0.95–1.07)
(Table 3).
However, further specific analysis on cancer type determined
that patients with AD had a significantly higher risk of prostate
cancer (HR=1.32, 95% CI=1.02–1.71) (Table 3); particularly in
the older age group ($65 years; HR=1.45, 95% CI=1.09–1.93)
(Table 4). In addition, we also observed that the AD cohort had a
significantly higher percentage than the non-AD cohort to
undergo prostate specific antigen (PSA) testing, regardless of the
age group (30–44 years, 7.83% vs. 2.92%; 45–54 years 32.0% vs.
12.1; 55–64 years, 46.2% vs. 25.2%; $65 years, 54.5% vs. 35.9%)
(Table 5). Table 3 also revealed that patients with AD had a
marginally significantly lower risk to develop cervical cancer
(HR=0.72, 95% CI=0.51–1.03), and Table 5 showed a
significantly higher percentage of AD cohort to undergo
Papanicolaous smear testing compared to non-AD cohort.
Discussion
In this population-based cohort study, the main finding was the
lack of an association between AD and the overall risk of cancer in
Taiwan; however, we obtained a number of interesting findings
related to the individual risk of cancer. Males with AD 65 years old
and older had a significantly higher risk of developing prostate
cancer. In contrast, females with AD had a marginally significantly
lower risk of developing cervical cancer.
As of 1982, cancer has been the leading cause of death among
the general population in Taiwan. The age-adjusted incidence rate
has increased steadily reaching 270 new cases per 100,000 in 2007
[18]. The trend is different from Surveillance Epidemiology and
End Results data, which showed that the overall incidence rates of
cancer for all racial/ethnic groups combined decreased by 0.7%
per year between 1999 and 2006 [19]. Because this issue remains a
challenge for the public health system in Taiwan, it has come to
the attention of the government, resulting in a population-based
investigation regarding cancer epidemiology and preventive. The
Taiwanese NHI health insurance program is a good resource
Table 2. Comparisons of incidence density of cancer between anxiety disorder group and non-anxiety disorder group by
characteristics.
Anxiety disorder
No Yes
Variables Cases Person-years Rate
{ Cases Person-years Rate
{ IRR (95% CI)
All 5,503 750,350 7.33 1,467 193,207 7.59 1.04 (0.98–1.10)
Sex
Women 2,994 490,473 6.10 801 126,440 6.34 1.04 (0.96–1.12)
Men 2,509 259,877 9.65 666 66,767 9.97 1.03 (0.95–1.13)
Age, years
30–44 563 240,916 2.34 169 61,461 2.75 1.18 (0.99–1.40)
45–54 1,087 204,396 5.32 290 51,421 5.64 1.06 (0.93–1.21)
55–64 1,298 144,457 8.99 341 36,672 9.30 1.03 (0.92–1.17)
$65 2,555 160,581 15.9 667 43,653 15.3 0.96 (0.88–1.05)
Urbanization level
1 1,502 227,091 6.61 364 51,455 7.07 1.07 (0.96–1.20)
2 1,562 216,528 7.21 388 54,886 7.07 0.98 (0.88–1.10)
3 906 130,615 6.94 228 31,686 7.20 1.04 (0.90–1.20)
4 851 99,830 8.52 269 32,156 8.37 0.98 (0.86–1.13)
5 682 76,276 8.94 218 23,024 9.47 1.06 (0.91–1.23)
Co-morbidity
Hypertension
No 3,314 565,762 5.86 609 109,651 5.55 0.95 (0.87–1.03)
Yes 2,189 184,589 11.9 858 83,556 10.3 0.87 (0.80–0.94)**
Diabetes mellitus
No 4,733 686,830 6.89 1,223 171,974 7.11 1.03 (0.97–1.10)
Yes 770 63,520 12.1 244 21,232 11.5 0.95 (0.82–1.09)
Hyperlipidemia
No 4,609 654,514 7.04 1,060 145,678 7.28 1.03 (0.97–1.10)
Yes 894 95,836 9.33 407 47,528 8.56 0.92 (0.82–1.03)
{per 1,000 person-year.
IRR: incidence rate ratio.
*p,0.05,
**p,0.001.
doi:10.1371/journal.pone.0036370.t002
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based studies. We recently used it to evaluate the risk of
malignancy for patients with systemic lupus erythematosus,
resulting in positive findings [20]. The current study used a
similar design in an attempt to identify a relationship between AD
and the risk of cancer.
To the best of our knowledge, this is the first population-based
study with a collection of 24,066 patients with AD in Taiwan. To
create a control group, we randomly frequency matched each AD
patient with 4 individuals from the general population without AD
but in a similar age, sex, and index calendar year. To compare
demographic characteristics between the two groups, our data
shows that patients with AD tended to have comorbidities. This is
expected because chronic illness may induce AD, and vice versa
[6,21,22]. The distribution of urbanization levels illustrated a
significantly higher prevalence of AD patients living in less
urbanized areas of Taiwan. This is consistent with a prior study
from Taiwan, indicating that individuals living in rural areas had a
higher risk of AD [4].
The potential relationship between AD and the overall risk of
cancer or any individual risk of cancer is still not well-recognized.
Although prior meta-analysis found a significant increase in the
overall risk of cancer for patients with psychological distress [16],
only a non-significant 1% increase in the overall risk of cancer risk
was observed in our study. With regard to the individual risk of
cancer, we analyzed the most common types of cancer in Taiwan
and the results show different directions for various forms of
cancer. However, only prostate cancer showed a significantly
different risk between AD and non-AD groups. Most previous
studies have focused on psychological factors and breast cancer,
and the results have been contradictory. Some studies showed an
increased risk of breast cancer [23,24], while such associations
Table 3. Hazard ratios and 95% confidence interval of cancer associated with anxiety disorder in Cox’s regression analysis in
different cancer.
Percentage of cancer
Variables Non- Anxiety disorder Anxiety disorder HR (95% CI)
Overall 5.73 6.10 1.01 (0.95–1.07)
Oral cancer 0.26 0.26 0.81 (0.40–1.61)
Colorectal cancer 0.86 0.84 0.92 (0.79–1.08)
Liver cancer 0.72 0.85 1.11 (0.95–1.30)
Lung cancer 0.74 0.81 1.05 (0.89–1.23)
Breast cancer (women only) 0.98 1.16 1.32 (0.95–1.34)
Cervical cancer (women only) 0.35 0.25 0.72 (0.51–1.03)**
Prostate cancer (men only) 0.66 1.00 1.32 (1.02–1.71)*
Other cancers 2.06 2.08 1.00 (0.88–1.15)
ICD-9-CM: oral cancer, 140.xx–149.xx; colorectal cancer, 153.xx and 154.xx; liver cancer, 155.xx; lung cancer, 162.xx; breast cancer, 174.xx; cervical cancer, 180.xx; prostate
cancer, 185.xx.
Adjusted for urbanization, hypertension, diabetes mellitus, and hyperlipidemia.
*p-value,0.05,
**p-value=0.0678.
doi:10.1371/journal.pone.0036370.t003
Table 4. Multivariable Cox’s regression analysis of cancer associated with anxiety disorder among age groups.
Percentage of cancer
Variables Non-Anxiety disorder Anxiety disorder HR (95% CI)
Prostate cancer (men only)
30–44 0.00 0.00 –
45–54 0.16 0.10 0.46 (0.10–2.14)
55–64 0.75 0.98 1.25 (0.68–2.29)
$65 1.63 2.66 1.45 (1.09–1.93)*
Cervical cancer (women only)
30–44 0.21 0.06 0.33 (0.10–1.06)
45–54 0.34 0.35 0.98 (0.55–1.76)
55–64 0.42 0.30 0.78 (0.38–1.60)
$65 0.50 0.32 0.67 (0.35–1.28)
Adjusted for urbanization, hypertension, diabetes mellitus, and hyperlipidemia.
*p,0.05,
**p,0.001,
***p,0.0001.
doi:10.1371/journal.pone.0036370.t004
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found only a modest association between specific psychosocial
factors and breast cancer, contrary to the conventional wisdom
that personality and stress influence the development of breast
cancer [26]. Our study showed a 32% increase in the risk of breast
cancer among patients with AD; however, the difference did not
reach statistical significance.
Our results show a significant increase in the risk of developing
prostate cancer, particularly in the older age group. This is a novel
finding not uncovered in previous studies [16]. One possible
reason is that patients with AD tend to check their health more
regularly, and are assumed to get routine check-ups, including
cancer screening more frequently than the general population.
Table 5 validates our assumption showing that patients with AD
consistently have significantly higher PSA rates among various age
groups. This may result in an increase in the early detection of
prostate cancer. The same explanation may also be implied for
patients with cervical cancer. We found a marginally significant
decrease (28%) in the incidence rate for invasive cervical cancer
among female patients with AD. More frequent Pap smear exams
could identify more patients with cervical CIS/CIN/dysplasia.
CIN and CIS lesions are known to precede invasive cancer in the
process of carcinogenesis for cervical cancer. Normally, these
patients receive treatment before the disease progresses into
invasive cancer. We did not include CIN/CIS as our end-point for
cervical cancer and this could decrease the relative number of
cases of invasive cervical cancer. The data from the table 5 further
supports this assumption. Table 1 revealed significant difference
for the distribution of urbanization levels between AD and non-
AD cohorts, and people live in the areas of higher urbanization
levels may have more frequently screened for cancer; however,
due to the limitation of the database, it is difficult to verify from
this study.
Psychological parameters could alter immune and endocrine
function, and it has long been hypothesized that, through this
pathway, psychosocial factors may influence the incidence of
cancer [27]. A growing body of evidence has implicated the
immune system as a link between the central nervous system and
the processes of disease [28]. A number of researchers in this field
have proven that external factors such as stress, depression, or
social support have a significant influence on the immune system,
which in turn influence the onset and/or the course of cancer [29].
The strength of this study is the population-based design with its
generalizability. However, one major limitation that needs to be
addressed is the lack of information regarding the life style or
behavior of patients in the NHI database, making it impossible to
adjust for health behavior related factors such as smoking and
alcohol consumption. Specific personality traits and various life
events are associated with health-related behavior and lifestyle
factors, e.g., smoking or unhealthy nutrition. These unhealthy
habits can increase the risk of cancer [27]; however, the
relationship between health behavior and AD remains controver-
sial [30,31].
In conclusion, this population-based retrospective cohort study
identified a significant increase in the incidence of prostate cancer
risk and a marginally significant decrease in the risk of cervical
cancer among Taiwanese patients with AD. The intrinsic
characteristic of patients with AD cause them to seek cancer
screening more frequently, and this fact contributes to the results.
The findings in this study may remind the NHI of Taiwan to
reconsider policy regarding follow-up and cancer screening in
patients with AD.
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